Corrigendum: A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs

Corrigendum: A novel model based on necroptosis to assess progression for polycystic ovary syndrome and identification of potential therapeutic drugs

Saved in:

Bibliographic Details
Main Authors:	Mingming Wang, Ke An, Jing Huang, Richard Mprah, Huanhuan Ding
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Series:	Frontiers in Endocrinology
Subjects:	polycystic ovary syndrome diagnostic model therapeutic drugs necroptosis gene signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1502142/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polycystic Ovary Syndrome (PCOS): Symptoms, Causes, and Treatment
by: Hai Bai, et al.
Published: (2024-05-01)

Estimation of the hepcidin level and some Biochemical parameters in patients of polycystic ovary Syndrome in Kirkuk city
by: Sherin Bahgat Ayed AL- Tikriti, et al.
Published: (2019-08-01)

Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
by: Mingqin Shi, et al.
Published: (2024-12-01)

Study of the Relationship between the Sonographic Appearance of the Ovaries in Polycystic Ovary Syndrome and Different PCO Phenotypes
by: Farideh Marmazi, et al.
Published: (2025-07-01)

Development of a computer program for the diagnosis of polycystic ovary syndrome in women of early reproductive age
by: A. Yu. Beglova, et al.
Published: (2020-03-01)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
by: Tahereh Ziaie, et al.
Published: (2013-09-01)

A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
by: Pu Yifu
Published: (2024-12-01)

Construction of a Novel Necroptosis-Related Signature in Rat DRG for Neuropathic Pain
by: Liu Y, et al.
Published: (2025-01-01)

The Prevalence of Prenatal Diabetes Mellitus in Rania City: Women with Polycystic Ovaries
by: Renas Mohamed, et al.
Published: (2023-04-01)

Evaluation of therapeutic effects of Crocin in patients with polycystic ovary syndrome: A randomized Double-Blind clinical trial
by: Fatemeh Saghafi, et al.
Published: (2025-08-01)

Histochemical Effect of Capsaicin Alone or in Combination with The Metformin on Ovaries Structure After Induced a Polycystic Ovary Syndrome by Letrozole in Rats
by: Alia Mohammed Khudier, Karim H. Al-derawi, Labeed A. Al- saad
Published: (2024-03-01)

RETRACTED ARTICLE: A novel necroptosis signature for predicting survival in lung adenocarcinoma
by: Kui Zang, et al.
Published: (2023-11-01)

GABA Dysfunction and Its Consequences in Women with Polycystic Ovary Syndrome
by: F Motafeghi, et al.
Published: (2025-03-01)

Evaluation of Oxidative Stress Parameters in Adolescents with Polycystic Ovary Syndrome
by: Demet Aygün Arı, et al.
Published: (2025-04-01)

Executive summary: indonesian guidelines on polycystic ovary syndrome management
by: Mila Maidarti, et al.
Published: (2025-05-01)

Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
by: Fuzhen Zhao, et al.
Published: (2024-11-01)

Editorial: Internal and external factors affecting polycystic ovary syndrome
by: Alexandra E. Butler, et al.
Published: (2025-04-01)

Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities
by: Huanju Liu, et al.
Published: (2025-09-01)

The role of mitochondrial dysfunction in ovarian granulosa cells in polycystic ovary syndrome
by: Xuejun Yan, et al.
Published: (2025-07-01)

The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01)

Immunological aspects of polycystic ovary syndrome: A review
by: Yulia A. Kandrashlina, et al.
Published: (2025-01-01)

Modern aspects of management of patients with polycystic ovary syndrome
by: N. V. Avramenko, et al.
Published: (2020-12-01)

Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
by: Tsuyoshi Baba
Published: (2025-01-01)

Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
by: Pingping Su, et al.
Published: (2025-02-01)

Polycystic ovary syndrome — disease of adults in childhood: methods of diagnostics and treatment
by: I. L. Nikitina, et al.
Published: (2021-06-01)

Violation of the Hormonal Spectrum in Polycystic Ovaries in Combination with Insulin Resistance. What is the Trigger: Insulin Resistance or Polycystic Ovary Disease?
by: Lomteva S V, et al.
Published: (2022-10-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
by: Thanyarat Wongwananuruk, et al.
Published: (2024-02-01)

LAPAROSCOPY FOR THE RECOVERY OF REPRODUCTIVE HEALTH IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
by: I. N. Medvedevа, et al.
Published: (2018-02-01)

Investigation of the prevalence of polycystic ovary syndrome in Hamedan province in 2021
by: Fatemeh Asadi, et al.
Published: (2025-03-01)

Relationship of hepcidin with Iron and lipids in patients with polycystic ovary Syndrome
by: Sherin Bahgat Ayed AL- Tikriti, et al.
Published: (2023-02-01)

Adipokines as biochemical marker of polycystic ovary syndrome in adolescents – review
by: Dominika Orszulak, et al.
Published: (2025-05-01)

Polycystic Ovary Syndrome - treatment update
by: Marta Szymura, et al.
Published: (2025-07-01)

Estimation the activity of Copeptin, insulin, and C-peptide from patients with polycystic ovary syndrome
by: Entedhar R. Sarhat, et al.
Published: (2018-08-01)

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
by: Paola Quaresima, et al.
Published: (2025-02-01)

Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01)

Effect and mechanism of resveratrol against polycystic ovary syndrome: a review
by: Hui Chang, et al.
Published: (2025-07-01)

Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
by: Rui Hua, et al.
Published: (2025-08-01)

Ayurvedic Management of Insulin Resistance-related Conditions in Polycystic Ovary Syndrome
by: Anshul Chauhan, et al.
Published: (2025-01-01)